Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Microcirculation. 2024 Nov;31(8):e12887. doi: 10.1111/micc.12887. Epub 2024 Sep 27.
Lymphatic muscle cells (LMCs) are indispensable for proper functioning of the lymphatic system, as they provide the driving force for lymph transport. Recent studies have advanced our understanding of the molecular mechanisms that regulate LMCs, which control rhythmic contraction and vessel tone of lymphatic vessels-traits also found in cardiac and vascular smooth muscle. In this review, we discuss the molecular pathways that orchestrate LMC-mediated contractility and summarize current knowledge about their developmental origin, which may shed light on the distinct contractile characteristics of LMCs. Further, we highlight the growing evidence implicating LMC dysregulation in the pathogenesis of lymphedema and other diseases related to lymphatic vessel dysfunction. Given the limited number and efficacy of existing therapies to treat lymphedema, LMCs present a promising focus for identifying novel therapeutic targets aimed at improving lymphatic vessel contractility. Here, we discuss LMCs in health and disease, as well as therapeutic strategies aimed at targeting them to improve lymphatic vessel function.
淋巴管肌细胞(LMCs)对于淋巴系统的正常功能是不可或缺的,因为它们为淋巴运输提供了驱动力。最近的研究提高了我们对调节 LMCs 的分子机制的理解,这些机制控制着淋巴管的节律性收缩和血管张力——这些特征也存在于心脏和血管平滑肌中。在这篇综述中,我们讨论了协调 LMC 介导的收缩性的分子途径,并总结了目前关于其发育起源的知识,这可能揭示了 LMC 独特的收缩特性。此外,我们强调了越来越多的证据表明 LMC 失调与淋巴水肿和其他与淋巴管功能障碍相关的疾病的发病机制有关。鉴于目前治疗淋巴水肿的疗法数量有限且效果有限,LMC 为确定旨在改善淋巴管收缩性的新型治疗靶点提供了一个有前途的重点。在这里,我们讨论了 LMC 在健康和疾病中的作用,以及旨在针对它们的治疗策略,以改善淋巴管功能。